Trial Profile
The Effect of Combination of Mosapride and Dipeptidyl Peptidase-4 (DPP-4) Inhibitor on Plasma Concentration of Incretin Hormones
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Mosapride (Primary) ; Linagliptin; Paracetamol
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 27 Nov 2017 Status changed from not yet recruiting to completed.
- 07 Jul 2014 New trial record